| |
Newsroom /
Health and Fitness
/
Healthcare
/
Indian Therapeutic Monoclonal Antibodies Market to Grow at a CAGR of 27% during 2011-2016
Indian Therapeutic Monoclonal Antibodies Market to Grow at a CAGR of 27% during 2011-2016
The study, that has been undertaken using desk-based as well as qualitative primary market research provides and draws upon a comprehensive analysis of the Indian therapeutic monoclonal antibodies market.
Noida,
Uttar pardesh,
India
(prbd.net)
15/03/2012
IMARC Group, one of the world’s leading research and advisory firms, in its latest study “Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016” finds that driven by factors such as a large patient pool, strong biomanufacturing capabilities, absence of an Indian patent for most in-market monoclonal antibodies and an increasing prevalence of health Insurance; the market for therapeutic monoclonal antibodies in India is expected to grow at a CAGR of 27% during 2011-2016. The study, that has been undertaken using desk-based as well as qualitative primary market research provides and draws upon a comprehensive analysis of the Indian therapeutic monoclonal antibodies market.
What we have achieved in this Report
Understanding the strengths, weaknesses, opportunities and challenges in the Indian therapeutic monoclonal antibodies market
Understanding the technological considerations and regulatory factors in the Indian therapeutic monoclonal antibodies market
• Evaluation and identification of monoclonal antibodies based on the sources from which they are derived and on the targets against which they act
• Understanding the key regulations for registering, manufacturing and importing therapeutic monoclonal antibodies in India
Evaluating the patent details of all globally marketed monoclonal antibodies in India, US and Europe
• Identifying the patentee name and patent numbers of all in-market monoclonal antibodies in India, US and Europe
• Identifying the monoclonal antibodies that are patent protected in India, US and Europe and those that are not
• Estimating the patent expiries of various monoclonal antibodies in India, US and Europe
Comprehensive situation analysis of the Indian therapeutic antibodies market
• Analyzing current and future sales of monoclonal antibodies in India
• Identifying all globally launched monoclonal antibodies and understanding their performance and launch status in India
• Analyzing the global and Indian monoclonal antibodies market by Indication
• Evaluation of the top selling monoclonal antibodies
• Key biosimilar antibody development programmes in India and abroad
Key Questions Answered in this Report:
• What is the current size and growth of the Indian therapeutic monoclonal antibodies market?
• What are the most popular indications for which therapeutic monoclonal antibodies are prescribed in India?
• Who are the key players operating in the Indian therapeutic monoclonal antibodies market?
• Which are the top selling therapeutic monoclonal antibodies in India?
• What are the strengths, weaknesses, opportunities and threats in the Indian therapeutic monoclonal antibodies market?
• What are the key requirements to launch a therapeutic monoclonal antibody in India?
• What is the patent position of various in-market therapeutic monoclonal antibodies in India?
• Which therapeutic monoclonal antibodies are protected by a patent in India and when will their patents expire?
• Which therapeutic monoclonal antibodies already have biosimilars available in India?
• What are the key biosimilar monoclonal antibody development programmes in India?
To obtain the complete report, please contact:
IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-425-6531
IMARC Group North America
Email: america@imarcgroup.com
Phone: +1-631-791-1145
To know more please visit: http://www.imarcgroup.com/indian-diagnostic-therapeutic-antibodies-market-report-forecast-2011-2016-2/
About
For more than 5 years, the International Market Analysis Research and Consulting Group has been a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
|